PCVX vs. ZS

In the year-to-date period, PCVX achieves a -59.78% return, which is significantly lower than ZS's 19.49% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vaxcyte, Inc. (PCVX) and Zscaler, Inc. (ZS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PCVX Sharpe Ratio is -0.61, which is lower than the ZS Sharpe Ratio of 0.49. The chart below compares the historical Sharpe Ratios of PCVX and ZS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither PCVX nor ZS has paid dividends to shareholders.

The maximum PCVX drawdown since its inception was -76.22%, roughly equal to the maximum ZS drawdown of -76.41%. Use the drawdown chart below to compare losses from any high point for PCVX and ZS. For additional features, visit the drawdowns tool.

Vaxcyte, Inc. (PCVX) has a higher volatility of 67.04% compared to Zscaler, Inc. (ZS) at 21.39%. This indicates that PCVX's price experiences larger fluctuations and is considered to be riskier than ZS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Vaxcyte, Inc. and Zscaler, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.